60 likes | 67 Vues
Autoimmune Disease Diagnostics Market Size 2030 - By Application, Type & Manufacturers Across North America, Europe, APAC, South America, MEA
E N D
Autoimmune Disease Diagnostics Market, Share, Growth, Trends and Forecast to 2030: Global Market Insights © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Market Scenario of Autoimmune Disease Diagnostics Market • Autoimmune Disease Diagnostics Market report gives attention to market segmentation, market size, and forecast of 2022-2030 to help stakeholders in making a good decision for the future investments. • Bioreactors industry report segmented into types, application, and regions with providing production, revenue, import/export. • Recently, a December 2021 study published in Cells analyzed the dysregulation of the immune system caused by the COVID-19 infection, which could lead to the development of autoimmune phenomena. • The research findings indicated that the coronavirus infection could precipitate systemic and rheumatic autoimmune diseases, establishing a link between the illness and new onset-rheumatic diseases to promote early diagnosis and timely therapeutic management. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Continue:- • Thus, the burgeoning need for diagnosing autoimmune diseases has fueled autoimmune disease diagnostics market growth considerably. Moreover, rapid advancements in autoimmune disease diagnostic systems have also stimulated business growth in the past few years. • Major companies have been focusing on strategic partnerships, mergers, collaborations, and product innovation to maintain a strong presence in the market, fostering the competitive outlook of the industry. • For instance, in March 2021, Bio-Rad Laboratories, a medical device company, extended its agreement with diagnostics behemoth Roche by offering its InteliQ product range. This deal aimed to fortify the partnership between the two firms. • The autoimmune disease diagnostics market has been bifurcated in terms of end-use, test type, disease type, and region. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
360° Industry Analysis • By disease type, the autoimmune disease diagnostics industry has been split into localized autoimmune disease and systemic autoimmune disease. • The systemic autoimmune disease segment was valued at more than $327 million in 2021 attributed to the growing influence of rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, and so on, which has increased the need for diagnosis of these conditions. • The autoimmune disease diagnostics market has been categorized on the basis of test type into urinalysis, antinuclear antibody tests, complete blood count (CBC), autoantibody tests, c-reactive protein (CRP), and others. • In 2021, the antinuclear antibody tests segment accounted for a revenue share of around 43% as a result of rising incidences of chronic ailments and diseases that target the immune systems such as type 1 diabetes, myasthenia gravis, and others. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Competitive Analysis: • Abbott Laboratories • Bio-rad Laboratories • F. Hoffmann-la Roche • Thermo Fisher Scientific • EUROIMMUN MedizinischeLabordiagnostika AG • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/autoimmune-disease-diagnostics-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com